Subject demographics in the 2 HIV+ groups: asymptomatic neurocognitive impairment and symptomatic HIV-associated neurocognitive disordera
| ANI | HAND | P Value | |
|---|---|---|---|
| No. | 24 | 21 | – |
| Age (yr) | 59.6 ± 5.7 | 58.2 ± 5.0 | .378 |
| Male sex (No.) (%) | 17 (71%) | 16 (76%) | .764 |
| Education (yr) | 14.9 ± 3.0 | 14.0 ± 2.7 | .263 |
| Race (% African American) | 12 (50%) | 13 (62%) | .655 |
| Duration of infection (yr) | 19.9 ± 9.0 | 19.2 ± 9.4 | .790 |
| CES-D | 7.7 ± 6.8 | 11.0 ± 11.7 | .253 |
| HART Est IQb | 112.9 ± 12.8 | 103.7 ± 12.9 | .022 |
| CD4 cell count (cells/mm3) | 674 ± 281 | 676 ± 375 | .988 |
| Plasma HIV RNA (Log10 copies/mL)c | 1.6 ± 0.1 | 2.3 ± 1.4 | .569 |
Note:—ANI indicates asymptomatic neurocognitive impairment; CES-D = Center for Epidemiological Studies Depression Scale; HART Est IQ = Hopkins Adult Reading Test estimated intelligence quotient.
↵a Values given are mean ± SD unless otherwise indicated.
↵b Significant (P < .05).
↵c Plasma HIV RNA only among those with detectable viral load (n = 2 ANI and n = 3 HAND).